We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
71.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.86%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$1.37B
AUM Growth
+$61.8M
(+4.7%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
11.44%
Holding
1,623
New
447
Increased
343
Reduced
364
Closed
410
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JHG
Janus Henderson
JHG
|
+$11.4M |
| 2 |
Roku
ROKU
|
+$8.72M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$8.2M |
| 4 |
Oracle
ORCL
|
+$7.64M |
| 5 |
NUVL
Nuvalent
NUVL
|
+$7.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$25.1M |
| 2 |
Seagate
STX
|
+$20.6M |
| 3 |
CWAN
Clearwater Analytics
CWAN
|
+$14.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$12.3M |
| 5 |
ACLX
Arcellx
ACLX
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.02% |
| 2 | Healthcare | 12.44% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 11.47% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Nu Skin
NUS
$223M
| $69.7K | 0.01% |
13,200
+887
| +7% | +$5.67K |
|
1152
GrafTech
EAF
$212M
| $69.5K | 0.01% |
+11,755
| New | +$99.3K |
|
1153
Zentalis Pharmaceuticals
ZNTL
$293M
| $67.1K | ﹤0.01% |
13,843
-6,557
| -32% | -$26.2K |
|
1154
Universal Electronics
UEIC
$66.2M
| $65.4K | ﹤0.01% |
13,708
-7,525
| -35% | -$31.3K |
|
1155
Similarweb
SMWB
$736M
| $63.8K | ﹤0.01% |
+10,411
| New | +$37.9K |
|
1156
CALL
International Money Express
IMXI
$399M
| $63.8K | ﹤0.01% |
+75,000
| New | +$1.15M |
|
1157
CALL
ZIM Integrated Shipping Services
ZIM
$3.53B
| $63.6K | ﹤0.01% |
+22,500
| New | +$581K |
|
1158
BioVie
BIVI
$14.7M
| $63.2K | ﹤0.01% |
32,583
-59,480
| -65% | -$93.4K |
|
|
XNET
1159
Xunlei
XNET
$313M
| $62.1K | ﹤0.01% |
+11,099
| New | +$64K |
|
|
AGEN
1160
Agenus
AGEN
$326M
| $60.5K | ﹤0.01% |
19,761
+4,861
| +33% | +$17.4K |
|
|
FGNX
1161
FG Nexus Inc
FGNX
$32.9M
| $60.1K | ﹤0.01% |
11,619
| – | – |
|
1162
Voyager Therapeutics
VYGR
$188M
| $59.9K | ﹤0.01% |
17,112
+1,400
| +9% | +$5.31K |
|
|
ATAI
1163
DELISTED
AtaiBeckley Inc
ATAI
| $58.9K | ﹤0.01% |
+11,167
| New | +$47K |
|
1164
PUT
Invesco QQQ Trust
QQQ
$474B
| $57.8K | ﹤0.01% |
+11,800
| New | +$8.12M |
|
1165
CALL
Payoneer
PAYO
$2.42B
| $57.5K | ﹤0.01% |
+50,000
| New | +$274K |
|
1166
Seer Inc
SEER
$105M
| $56.3K | ﹤0.01% |
33,887
-10,165
| -23% | -$18.4K |
|
|
BBCQW
1167
DELISTED
Bleichroeder Acquisition Corp II Warrants
BBCQW
| $54.5K | ﹤0.01% |
+25,000
| New | +$42.9K |
|
1168
GoPro
GPRO
$262M
| $54.4K | ﹤0.01% |
69,960
-10,815
| -13% | -$11.4K |
|
1169
Protalix BioTherapeutics
PLX
$216M
| $52.9K | ﹤0.01% |
22,700
+3,800
| +20% | +$8.05K |
|
1170
Alvotech
ALVO
$1.82B
| $52.1K | ﹤0.01% |
+14,127
| New | +$50.5K |
|
1171
Burford Capital
BUR
$850M
| $51.3K | ﹤0.01% |
12,501
-32,607
| -72% | -$149K |
|
1172
Denison Mines
DNN
$2.55B
| $49.8K | ﹤0.01% |
16,286
| – | – |
|
|
KGEI
1173
Kolibri Global Energy
KGEI
$246M
| $49.8K | ﹤0.01% |
+10,000
| New | +$53.4K |
|
1174
CareCloud
CCLD
$88.8M
| $49.2K | ﹤0.01% |
+23,200
| New | +$60K |
|
|
CMRC
1175
Commerce.com Inc Series 1
CMRC
$284M
| $46.6K | ﹤0.01% |
15,745
-17,792
| -53% | -$51K |
|
Similar funds
CA
MCI
WC
OCAI
AIP
FBCM
FCM
KPF
Prelude Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Prelude Capital Management held 1,623 positions worth $1.37B, up 4.7% from $1.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Prelude Capital Management withdrew a net $119M in Q2 2026, closing 410 positions and reducing 364 holdings. Its most notable exit was Clearwater Analytics, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Prelude Capital Management opened a new position in Vanguard S&P 500 ETF worth $8.44M.
- Prelude Capital Management's largest Q2 2026 buy was Vanguard S&P 500 ETF: 12,295 shares worth $8.44M.
- Prelude Capital Management added most to Janus Henderson in Q2 2026, an estimated $11.4M increase.
- Prelude Capital Management's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $25.1M.
- Prelude Capital Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $14.7M.
- Prelude Capital Management's ten largest holdings make up 11% of its $1.37B portfolio in Q2 2026.
- Prelude Capital Management opened 447 new positions and closed 410 in Q2 2026.
- Prelude Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.37B.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.